Literature DB >> 29021387

Timing of onset of symptoms in people with idiopathic pulmonary fibrosis.

Thomas Hewson1, Tricia M McKeever1, Jack E Gibson1, Vidya Navaratnam1, Richard B Hubbard1, John P Hutchinson1.   

Abstract

Little is known about when symptoms of idiopathic pulmonary fibrosis first develop. We identified incident cases of idiopathic pulmonary fibrosis-clinical syndrome (IPF-CS) from a UK primary care database and assessed the frequency of consultations for common symptoms in the 5 years prior to diagnosis. 1671 cases were identified with 5 years of data prior to diagnosis. Breathlessness was the most common symptom, followed by cough. Cases were significantly more likely than controls to experience these symptoms (p<0.001), even 4-5 years before diagnosis (OR for breathlessness for this period 2.79, 95% CI 2.13 to 3.65). This suggests that some patients with IPF may be symptomatic for more than 5 years before diagnosis. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  clinical epidemiology; idiopathic pulmonary fibrosis

Year:  2017        PMID: 29021387     DOI: 10.1136/thoraxjnl-2017-210177

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  [68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity.

Authors:  Zachary T Rosenkrans; Christopher F Massey; Ksenija Bernau; Carolina A Ferreira; Justin J Jeffery; Jefree J Schulte; Melissa Moore; Frank Valla; Jeanine M Batterton; Christopher R Drake; Alan B McMillan; Nathan Sandbo; Ali Pirasteh; Reinier Hernandez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-12       Impact factor: 10.057

2.  Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis.

Authors:  Severi Seppälä; Kaisa Rajala; Juho Tuomas Lehto; Eva Sutinen; Laura Mäkitalo; Hannu Kautiainen; Hannu Kankaanranta; Mari Ainola; Tiina Saarto; Marjukka Myllärniemi
Journal:  ERJ Open Res       Date:  2020-10-05

3.  Historical database cohort study addressing the clinical patterns prior to idiopathic pulmonary fibrosis (IPF) diagnosis in UK primary care.

Authors:  David Thickett; Jaco Voorham; Ronan Ryan; Rupert Jones; Robina Coker; Andrew M Wilson; Sen Yang; Mandy Yl Ow; Priyanka Raju; Isha Chaudhry; Antony Hardjojo; Victoria Carter; David B Price
Journal:  BMJ Open       Date:  2020-05-30       Impact factor: 2.692

4.  Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry.

Authors:  Laurie D Snyder; Christopher Mosher; Colin H Holtze; Lisa H Lancaster; Kevin R Flaherty; Imre Noth; Megan L Neely; Anne S Hellkamp; Shaun Bender; Craig S Conoscenti; Joao A de Andrade; Timothy Pm Whelan
Journal:  BMJ Open Respir Res       Date:  2020-07

5.  Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis.

Authors:  Marilyn K Glassberg; Marlies S Wijsenbeek; Frank Gilberg; Ute Petzinger; Klaus-Uwe Kirchgaessler; Carlo Albera
Journal:  Eur Respir J       Date:  2019-09-30       Impact factor: 16.671

Review 6.  Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes.

Authors:  Jaume Sauleda; Belén Núñez; Ernest Sala; Joan B Soriano
Journal:  Med Sci (Basel)       Date:  2018-11-29

7.  Dynamics in diagnoses and pharmacotherapy before and after diagnosing idiopathic pulmonary fibrosis.

Authors:  Jesper Rømhild Davidsen; Lars Christian Lund; Christian B Laursen; Jesper Hallas; Daniel Pilsgaard Henriksen
Journal:  ERJ Open Res       Date:  2020-11-10

8.  Idiopathic Pulmonary Fibrosis Complicated by Adenocarcinoma and Organizing Pneumonia.

Authors:  Yu Inutsuka; Toyoshi Yanagihara; Kotaro Matsumoto; Reiko Yoneda; Mikiko Hashisako; Naruhiko Ogo; Tatsuma Asoh; Takashige Maeyama
Journal:  Cureus       Date:  2022-01-04

Review 9.  Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat.

Authors:  Toby M Maher; Mary E Strek
Journal:  Respir Res       Date:  2019-09-06

10.  High resolution computed tomography patterns in interstitial lung disease (ILD): prevalence and prognosis.

Authors:  Renata Fragomeni Almeida; Guilherme Watte; Edson Marchiori; Stephan Altmayer; Gabriel Sartori Pacini; Marcelo Cardoso Barros; Aldo Paza Junior; Adalberto Sperb Runin; Moacyr Christopher Garces Gamarra Salem; Bruno Hochhegger
Journal:  J Bras Pneumol       Date:  2020-03-09       Impact factor: 2.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.